Search

Your search keyword '"Tsironis, G."' showing total 8 results
Start Over Author "Tsironis, G." Journal annals of oncology
8 results on '"Tsironis, G."'

1. Expression analysis of NHEJ and HR genes in Ewing sarcomas: Indications of DSB repair dysfunction

Author

Kyriazoglou, A., primary, Konteles, V., additional, Liontos, M., additional, Sofianidis, G., additional, Zagouri, F., additional, Koutsoukos, K., additional, Tsironis, G., additional, Tsiara, A., additional, Kaparelou, M., additional, Zakopoulou, R., additional, Cohen, A., additional, Dimitriadis, E., additional, Mahaira, L., additional, Michali, D., additional, Arnogiannaki, N., additional, Stefanaki, K., additional, Dimopoulos, M.A.C., additional, and Kattamis, A., additional

Published
2019
Full Text
View/download PDF

2. Evaluation of chemotherapy response score and lymphocytic infiltration as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

Author

Liontos, M., primary, Sotiropoulou, M., additional, Kaparelou, M., additional, Tzannis, K., additional, Tsironis, G., additional, Kyriazoglou, A., additional, Tsiara, A., additional, Zakopoulou, R., additional, Koutsoukos, K., additional, Zagouri, F., additional, Vlachos, D., additional, Thomakos, N., additional, Haidopoulos, D., additional, Rodolakis, A., additional, Dimopoulos, M.A.C., additional, and Bamias, A., additional

Published
2018
Full Text
View/download PDF

4. Prognostic and predictive significance of VEGF and TNF&agr; levels in ascites of patients with epithelial ovarian cancer. Correlation with lymphocytes subpopulations

Author

Liontos, M., primary, Gavalas, N., additional, Tzanis, K., additional, Trachana, S.-P., additional, Kostouros, E., additional, Zagouri, F., additional, Koutsoukos, K., additional, Lykka, M., additional, Tsironis, G., additional, Dimitriadis, I., additional, Terpos, E., additional, Dimopoulos, M., additional, and Bamias, A., additional

Published
2016
Full Text
View/download PDF

5. Efficacy and safety of the combination of bevacizumab (BEV) and temsirolimus (TEM) in patients with metastatic renal cancer (mRCC) after first-line anti-VEGF treatment: A Hellenic Cooperative Oncology group (HeCOG) phase II trial

Author

Koutsoukos, K., primary, Zagouri, F., additional, Tzannis, K., additional, Karavasilis, V., additional, Samantas, E., additional, Aravantinos, G., additional, Koutras, A., additional, Gkerzelis, I., additional, Chamylos, E., additional, Kostouros, E., additional, Lykka, M., additional, Tsironis, G., additional, Dimitriadis, I., additional, Liontos, M., additional, Fountzilas, G., additional, Dimopoulos, M., additional, and Bamias, A., additional

Published
2016
Full Text
View/download PDF

8. 824P - Efficacy and safety of the combination of bevacizumab (BEV) and temsirolimus (TEM) in patients with metastatic renal cancer (mRCC) after first-line anti-VEGF treatment: A Hellenic Cooperative Oncology group (HeCOG) phase II trial

Author

Koutsoukos, K., Zagouri, F., Tzannis, K., Karavasilis, V., Samantas, E., Aravantinos, G., Koutras, A., Gkerzelis, I., Chamylos, E., Kostouros, E., Lykka, M., Tsironis, G., Dimitriadis, I., Liontos, M., Fountzilas, G., Dimopoulos, M., and Bamias, A.

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results